Treatment-resistant Schizophrenia

• CLINICAL_TRIALS trial_result · 2025-03-06
  Clinical Trial Update: Neural Biomarkers of Clozapine Response

  A completed clinical trial from the University of Pittsburgh examining neural biomarkers associated with clozapine response in schizophrenia…

• CLINICAL_TRIALS trial_result · 2023-09-29
  Clinical Trial Update: Multidisciplinary Design to Optimize Schizophrenia Treatment Based on Multi-omics Data and Systems Biology Analysis [Phase 4]

  Phase 4 clinical trial update exploring multidisciplinary design to optimize schizophrenia treatment using multi-omics data and systems biol…

• CLINICAL_TRIALS trial_result · 2023-07-20
  Clinical Trial Update: Add-on Aripiprazole on Cardiometabolic Profile in Treatment Resistant Schizophrenia: RCT [Phase 4]

  Phase 4 clinical trial evaluating add-on aripiprazole and its effect on cardiometabolic risk in treatment-resistant schizophrenia.

• CLINICAL_TRIALS trial_result · 2022-03-02
  Clinical Trial Update: Telmisartan Pilot Study on Treatment Resistant Schizophrenia [Phase 2]

  Phase 2 pilot study on telmisartan for treatment-resistant schizophrenia was terminated with posted results.

• CLINICAL_TRIALS trial_result · 2021-06-16
  Clinical Trial Update: Comparison of Maintenance ECT Versus Clozapine in Treatment-resistant Schizophrenia [Phase 4]

  Phase 4 clinical trial comparing maintenance electroconvulsive therapy versus clozapine in treatment-resistant schizophrenia has completed.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2020-08-27
  Clinical Trial Update: SMART Design to Compare Antipsychotic Treatments in Treatment-Resistant Schizophrenia [Phase 3]

  Phase 3 trial design update comparing antipsychotic treatments for treatment-resistant schizophrenia; status and full results are not provid…

• CLINICAL_TRIALS trial_result · 2020-01-07
  Clinical Trial Update: Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia [Phase 3]

  Phase 3 trial of Lu AF35700 in treatment-resistant schizophrenia was terminated; results were posted in 2020.

• CLINICAL_TRIALS trial_result · 2013-10-29
  Clinical Trial Update: GlyT-1 Inhibitor Treatment for Refractory Schizophrenia [Phase 2]

  Phase 2 clinical trial update reporting completion of testing for a GlyT-1 inhibitor in treatment-refractory schizophrenia.